COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 619.1 | 9 | 0031-0392 | 112.90 | 392.27 | 302 | 70.18 | 0.770 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 499.7 | 9 | 0032-0394 | 544.89 | 393.62 | 265 | 87.64 | 0.434 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 430.0 | 9 | 0033-0396 | 427.88 | 397.25 | 206 | 56.77 | 0.803 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 517.6 | 9 | 0034-0412 | 642.60 | 412.11 | 280 | 69.26 | 0.734 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 886.4 | 9 | 0035-0416 | 462.97 | 416.38 | 197 | 60.28 | 0.681 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 800.5 | 9 | 0036-0419 | 369.72 | 418.83 | 238 | 60.53 | 0.816 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 390.5 | 9 | 0037-0428 | 443.00 | 427.25 | 275 | 64.77 | 0.824 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 415.9 | 9 | 0038-0429 | 515.38 | 429.72 | 271 | 61.70 | 0.895 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 355.0 | 9 | 0039-0440 | 364.69 | 440.16 | 252 | 61.01 | 0.851 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 412.5 | 9 | 0040-0502 | 687.24 | 501.40 | 247 | 61.36 | 0.825 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 408.2 | 9 | 0041-0505 | 670.84 | 506.14 | 206 | 54.63 | 0.867 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 555.1 | 9 | 0042-0526 | 480.04 | 525.65 | 299 | 66.77 | 0.843 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 455.3 | 9 | 0043-0560 | 241.00 | 560.24 | 284 | 66.77 | 0.801 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 1091.7 | 9 | 0044-0582 | 19.55 | 581.95 | 287 | 64.53 | 0.866 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 784.5 | 9 | 0045-0581 | 306.88 | 581.25 | 226 | 58.18 | 0.839 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 429.1 | 9 | 0046-0596 | 783.57 | 595.75 | 266 | 63.84 | 0.820 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 814.9 | 9 | 0047-0601 | 698.86 | 601.44 | 250 | 62.53 | 0.804 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 340.9 | 9 | 0048-0605 | 942.34 | 604.53 | 260 | 67.01 | 0.728 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 333.8 | 9 | 0049-0613 | 300.09 | 612.81 | 325 | 66.43 | 0.926 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-1 | KI-67 / clone D3B5 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | KI-67 | | 303.3 | 9 | 0050-0664 | 878.63 | 665.31 | 280 | 63.60 | 0.870 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1039.4 | 1 | 0001-0030 | 113.89 | 29.84 | 299 | 67.60 | 0.822 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1501.2 | 1 | 0002-0029 | 168.91 | 28.72 | 294 | 66.18 | 0.843 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 5638.9 | 1 | 0003-0033 | 263.30 | 34.12 | 210 | 55.36 | 0.861 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1428.6 | 1 | 0004-0039 | 463.46 | 39.70 | 310 | 65.36 | 0.912 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1043.9 | 1 | 0005-0040 | 504.82 | 41.10 | 293 | 68.67 | 0.781 |